Getty ImagesShares of the Ltd. traded at Rs 693.6 on BSE at 12:30PM (IST) on Tuesday, up 1.2 per cent. The stock quoted a 52-week low price of Rs 660.1 and a high of Rs 1063.75.
Earlier in the day, the stock saw a gap up opening.
At the prevailing price, the stock traded at 7.63 times its trailing 12-month EPS of Rs 90.87 per share and 2.36 times its book value, as per BSE data.
A total of 26,824 shares changed hands on the counter till 12:30PM (IST). The stock commands a market value of Rs 40640.7 crore and is part of the Pharma - Indian industry.
The scrip has been an underperformer , down 11.6 per cent in the past one year in comparison with a 50.36 per cent gain in Sensex.
During the day, the stock moved between Rs 698.6 and Rs 684.9.
Promoter/FII Holding
Promoters held 48.76 per cent in the company as of 30-Sep-2021. FII and MF ownership in Aurobindo Pharma Ltd. stood at 21.71 per cent and 9.28 per cent, respectively.
Earlier in the day, the stock saw a gap up opening.
At the prevailing price, the stock traded at 7.63 times its trailing 12-month EPS of Rs 90.87 per share and 2.36 times its book value, as per BSE data.
A total of 26,824 shares changed hands on the counter till 12:30PM (IST). The stock commands a market value of Rs 40640.7 crore and is part of the Pharma - Indian industry.
The scrip has been an underperformer , down 11.6 per cent in the past one year in comparison with a 50.36 per cent gain in Sensex.
During the day, the stock moved between Rs 698.6 and Rs 684.9.
Promoter/FII Holding
Promoters held 48.76 per cent in the company as of 30-Sep-2021. FII and MF ownership in Aurobindo Pharma Ltd. stood at 21.71 per cent and 9.28 per cent, respectively.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
